New Zealand consultant ophthalmologist Dr Dean Corbett has successfully implanted the Samsara Vision’s SING IMT (smaller-incision new-generation implantable miniature telescope) in a patient with age-related macular degeneration (AMD).
A new study has shown a drug commonly used to treat Parkinson’s disease may offer protection against neovascular age-related macular degeneration (nAMD).
A study from the University of Wuhan, China, has confirmed the association between meibomian gland dysfunction (MGD) and demodex infestation with the incidence of recurrent corneal erosion syndrome (R
Arizona State University researchers are developing new diagnostic tools harnessing the power of artificial intelligence (AI) to improve myopic maculopathy screening. Winning the 2023 Medical I
Authors of a Chinese study of corneal epithelial ingrowth (EI), a rare but significant complication following laser refractive surgery, said their results offer alternative treatment paths and challen
The Australian ‘Kruk Review’, designed to remove regulatory road blocks to attract more internationally qualified healthcare practitioners (IQHPs) to the region, "disempowers our colleges”, said Austr
A study of oral gildeuretinol acetate (ALK-001) in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) demonstrated a significant reduction of lesion growth rate
New research shows the overwhelming majority of New Zealand workers (81%) say they feel burnt out at work with many (24%) not sharing their struggles with their manager.
Aurion Biotech announced Vyznova (neltependocel) – which it says is the first treatment for bullous keratopathy of the cornea – has been launched in Japan. Having received regulatory and reimburs
Despite the promise of an additional 3,500 cataract surgeries in the 18 months from July 2023, NZ's cataract waitlist has grown by 696 patients.
Betaxolol eye drops, branded Betoptic and Betoptic S, are being discontinued globally by Novartis, Pharmac advised.
The Australian and New Zealand Eye Foundation (ANZEF), the philanthropic arm of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO), has announced its grant recipients for 2024.
